LOSS OF SERUM HBV DNA AND HBEAG AND SEROCONVERSION FOLLOWING SHORT-TERM (12 WEEKS) ADEFOVIR DIPIVOXIL THERAPY IN CHRONIC HEPATITIS-B - 2 PLACEBO-CONTROLLED PHASE-II STUDIES

HEATHCOTE EJ JEFFERS L WRIGHT T SHERMAN M PERRILLO R SACKS S CARITHERS R RUSTGI V DIBISCEGLIE A VALAN V MURRAY A ROONEY J JAFFE HS

Ej. Heathcote et al., LOSS OF SERUM HBV DNA AND HBEAG AND SEROCONVERSION FOLLOWING SHORT-TERM (12 WEEKS) ADEFOVIR DIPIVOXIL THERAPY IN CHRONIC HEPATITIS-B - 2 PLACEBO-CONTROLLED PHASE-II STUDIES, Hepatology, 28(4), 1998, pp. 620-620

NO

Gastroenterology & Hepatology

Hepatology → ACNP

02709139

28

4

1998

2

S

620 - 620

ISI

0270-9139(1998)28:4<620:LOSHDA>2.0.ZU;2-X